<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Vaccine Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Clin. Vaccine Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">372</journal-id><journal-id journal-id-type="pmc-domain">cvi</journal-id><journal-id journal-id-type="publisher-id">CVI</journal-id><journal-title-group><journal-title>Clinical and Vaccine Immunology : CVI</journal-title></journal-title-group><issn pub-type="ppub">1556-6811</issn><issn pub-type="epub">1556-679X</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC4248782</article-id><article-id pub-id-type="pmcid-ver">PMC4248782.1</article-id><article-id pub-id-type="pmcaid">4248782</article-id><article-id pub-id-type="pmcaiid">4248782</article-id><article-id pub-id-type="pmid">25339409</article-id><article-id pub-id-type="doi">10.1128/CVI.00527-14</article-id><article-id pub-id-type="publisher-id">00527-14</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Vaccines</subject></subj-group></article-categories><title-group><article-title>Evaluation of the Efficacy of Outer Membrane Protein 31 Vaccine Formulations for Protection against <named-content content-type="genus-species">Brucella canis</named-content> in BALB/c Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Clausse</surname><given-names initials="M">Maria</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>D&#237;az</surname><given-names initials="AG">Alejandra G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Iba&#241;ez</surname><given-names initials="AE">Andr&#233;s E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cassataro</surname><given-names initials="J">Juliana</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Giambartolomei</surname><given-names initials="GH">Guillermo H.</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Estein</surname><given-names initials="SM">Silvia M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Laboratorio de Inmunolog&#237;a, Departamento SAMP, Facultad de Ciencias Veterinarias, Centro de Investigaci&#243;n Veterinaria de Tandil (CIVETAN-CONICET), Universidad Nacional del Centro de la Provincia de Buenos Aires, Tandil, Argentina</aff><aff id="aff2"><label>b</label>Instituto de Inmunolog&#237;a, Gen&#233;tica y Metabolismo (CONICET/UBA), Buenos Aires, Argentina</aff></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Burns</surname><given-names initials="DL">D. L.</given-names></name><role>Editor</role></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Silvia M. Estein, <email>silmares@vet.unicen.edu.ar</email>.</corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2014</year></pub-date><volume>21</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">245891</issue-id><fpage>1689</fpage><lpage>1694</lpage><history><date date-type="received"><day>4</day><month>8</month><year>2014</year></date><date date-type="rev-request"><day>28</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2014</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2015</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2015</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2015-06-01 00:13:01.340"><day>01</day><month>06</month><year>2015</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2014, American Society for Microbiology. All Rights Reserved.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>American Society for Microbiology</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="zcd1689.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="zcd01214001689.pdf"/><abstract><p>Canine brucellosis is an infectious disease caused by the Gram-negative bacterium <named-content content-type="genus-species">Brucella canis</named-content>. Unlike conventional control programs for other species of the genus <named-content content-type="genus-species">Brucella</named-content>, currently there is no vaccine available against canine brucellosis, and preventive measures are simply diagnosis and isolation of infected dogs. New approaches are therefore needed to develop an effective and safe immunization strategy against this zoonotic pathogen. In this study, BALB/c mice were subcutaneously immunized with the following: (i) the recombinant <named-content content-type="genus-species">Brucella</named-content> Omp31 antigen formulated in different adjuvants (incomplete Freund adjuvant, aluminum hydroxide, Quil A, and Montanide IMS 3012 VGPR), (ii) plasmid pCIOmp31, or (iii) pCIOmp31 plasmid followed by boosting with recombinant Omp31 (rOmp31). The immune response and the protective efficacy against <named-content content-type="genus-species">B. canis</named-content> infection were characterized. The different strategies induced a strong immunoglobulin G (IgG) response. Furthermore, spleen cells from rOmp31-immunized mice produced gamma interferon and interleukin-4 (IL-4) after <italic toggle="yes">in vitro</italic> stimulation with rOmp31, indicating the induction of a mixed Th1-Th2 response. Recombinant Omp31 administered with different adjuvants as well as the prime-boost strategy conferred protection against <named-content content-type="genus-species">B. canis</named-content>. In conclusion, our results suggest that Omp31 could be a useful candidate for the development of a subcellular vaccine against <named-content content-type="genus-species">B. canis</named-content> infection.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>